Histoplasmosis in Inflammatory Bowel Disease with Tumor Necrosis Factor-Alpha Inhibitors: Safe to Continue Biologics?

被引：0
|
作者：
Claire L. Jansson-Knodell
Courtney E. Harris
Edward V. Loftus
Randall C. Walker
Mark J. Enzler
Abinash Virk
机构：
[1] Indiana University,Division of Gastroenterology and Hepatology
[2] Mayo Clinic,Department of Internal Medicine
[3] Mayo Clinic,Division of Gastroenterology and Hepatology
[4] Mayo Clinic,Division of Infectious Diseases
来源：
Digestive Diseases and Sciences | 2021年 / 66卷
关键词：
Fungal infection; Infliximab; Adalimumab; Certolizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：190 / 198
页数：8
相关论文
共 50 条
  • [21] Incidence and Risk Factors for Invasive Fungal Infections in Patients Initiating Tumor Necrosis Factor-Alpha Inhibitors for Inflammatory Bowel Disease and Rheumatoid Arthritis
    Hennessee, Ian
    Benedict, Kaitlin
    Bahr, Nathan C.
    Lipner, Shari R.
    Gold, Jeremy A. W.
    CLINICAL INFECTIOUS DISEASES, 2024,
  • [22] TREATMENT OF INFLAMMATORY BOWEL-DISEASE USING ANTITUMOR NECROSIS FACTOR-ALPHA ANTIBODY
    WATKINS, PE
    FOULKES, R
    STEPHENS, S
    WARD, P
    WARREN, BF
    BRITISH JOURNAL OF SURGERY, 1995, 82 (05) : 693 - 694
  • [23] Tumor necrosis factor-alpha concentrations in whole gut lavage fluid do not represent disease activity in inflammatory bowel disease
    Krumm, PJJM
    vanDijk, APM
    Tak, CJAM
    Zijlstra, FJ
    vanBlankenstein, M
    Wilson, JHP
    GASTROENTEROLOGY, 1996, 110 (04) : A942 - A942
  • [24] Cutaneous pseudolymphoma induced by tumor necrosis factor-alpha inhibitors
    Yokota, Masaki
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (06) : E217 - E219
  • [25] Bradypnea in a child taking tumor necrosis factor-alpha inhibitors
    Sener, Seher
    Basaran, Ozge
    Bilginer, Yelda
    Kiper, Nural
    Ozen, Seza
    PEDIATRIC PULMONOLOGY, 2022, 57 (09) : 2267 - 2268
  • [26] Biarylcarboxamide inhibitors of phosphodiesterase IV and tumor necrosis factor-alpha
    Chambers, RJ
    Marfat, A
    Cheng, JB
    Cohan, VL
    Damon, DB
    Duplantier, AJ
    Hibbs, TA
    Jenkinson, TH
    Johnson, KL
    Kraus, KG
    Pettipher, ER
    Salter, ED
    Shirley, JT
    Umland, JP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (06) : 739 - 744
  • [27] Hyperactive neutrophil chemotaxis contributes to anti-tumor necrosis factor-alpha treatment resistance in inflammatory bowel disease
    Yau, Tung On
    Vadakekolathu, Jayakumar
    Foulds, Gemma Ann
    Du, Guodong
    Dickins, Benjamin
    Polytarchou, Christos
    Rutella, Sergio
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (03) : 531 - 541
  • [28] Role of Tumor Necrosis Factor-Alpha (C-863A) Polymorphism in Pathogenesis of Inflammatory Bowel Disease in Northern India
    Dinesh K. Ahirwar
    Pravin Kesarwani
    Ranjana Singh
    Uday Chand Ghoshal
    Rama Devi Mittal
    Journal of Gastrointestinal Cancer, 2012, 43 (2) : 196 - 204
  • [29] Efficacy of iron supplementation in patients with inflammatory bowel disease treated with anti-tumor necrosis factor-alpha agents
    Kim, Su Young
    An, Sejin
    Park, Dong Kyun
    Kwon, Kwang An
    Kim, Kyoung Oh
    Chung, Jun-Won
    Kim, Jung Ho
    Kim, Yoon Jae
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [30] Liver Diseases Associated with Anti-Tumor Necrosis Factor-alpha (TNF-α) Use for Inflammatory Bowel Disease
    Coffin, Carla S.
    Fraser, Hughie F.
    Panaccione, Remo
    Ghosh, Subrata
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (01) : 479 - 484
12345